• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Colchicine for Secondary Prevention in Established ASCVD: A Systematic Review and Meta-Analysis.

作者信息

Abdelaziz Ahmed, Sobhy Ahmed, Nazmy Ahmed, Atta Karim, Elshahat Ahmed, Abdelaziz Mohamed, Lorenzatti Daniel, Radparvar Ashley, Kuno Toshiki, Filtz Annalisa, Lavie Carl J, Gulati Martha, Bhatt Deepak L, Virani Salim S, Shapiro Michael D, Slipczuk Leandro

机构信息

Medical Research Group of Egypt (MRGE), Negida Academy, Arlington, MA, USA.

Division of Cardiology, Montefiore Health System/Albert Einstein College of Medicine, Bronx, NY, USA.

出版信息

Eur J Prev Cardiol. 2025 Jun 12. doi: 10.1093/eurjpc/zwaf332.

DOI:10.1093/eurjpc/zwaf332
PMID:40504868
Abstract
摘要

相似文献

1
Colchicine for Secondary Prevention in Established ASCVD: A Systematic Review and Meta-Analysis.
Eur J Prev Cardiol. 2025 Jun 12. doi: 10.1093/eurjpc/zwaf332.
2
Magnitude of effect of low dose colchicine, a newly food and drug administration approved treatment for stroke prevention.低剂量秋水仙碱（一种新获得美国食品药品监督管理局批准用于预防中风的治疗药物）的疗效强度
J Stroke Cerebrovasc Dis. 2025 Feb;34(2):108186. doi: 10.1016/j.jstrokecerebrovasdis.2024.108186. Epub 2024 Dec 10.
3
Comparative Efficacy of Colchicine and Intensive Low-density Lipoprotein Cholesterol Lowering in Patients with Atherosclerotic Diseases receiving Statins: A Network Meta-analysis of Randomized Controlled Trials.秋水仙碱与强化降低低密度脂蛋白胆固醇在接受他汀类药物治疗的动脉粥样硬化疾病患者中的疗效比较：一项随机对照试验的网状荟萃分析
Cardiovasc Drugs Ther. 2024 Aug 29. doi: 10.1007/s10557-024-07622-9.
4
Association between colchicine use and adverse cardiovascular events in patients with gout: a nationwide nested case-control study.
Rheumatology (Oxford). 2025 May 1;64(5):2601-2608. doi: 10.1093/rheumatology/keae545.
5
Efficacy of Colchicine for Secondary Prevention of Stroke: A Systematic Review and Meta-Analysis of Randomized Control Trials.秋水仙碱用于卒中二级预防的疗效：随机对照试验的系统评价和荟萃分析
Cureus. 2024 Dec 8;16(12):e75335. doi: 10.7759/cureus.75335. eCollection 2024 Dec.
6
The efficacy and safety of low dose colchicine in atherosclerotic cardiovascular disease - A systematic review and meta-analysis.
Eur J Prev Cardiol. 2025 May 16. doi: 10.1093/eurjpc/zwaf302.
7
Impact of the 2021 European Society for Cardiology prevention guideline's stepwise approach for cardiovascular risk factor treatment in patients with established atherosclerotic cardiovascular disease.2021 年欧洲心脏病学会预防指南对已患有动脉粥样硬化性心血管疾病患者心血管危险因素治疗的逐步方法的影响。
Eur J Prev Cardiol. 2024 Apr 18;31(6):754-762. doi: 10.1093/eurjpc/zwae038.
8
The effect of telemedicine on secondary prevention of atherosclerotic cardiovascular disease: A systematic review and meta-analysis.远程医疗对动脉粥样硬化性心血管疾病二级预防的影响：一项系统评价和荟萃分析。
Front Cardiovasc Med. 2022 Nov 3;9:1020744. doi: 10.3389/fcvm.2022.1020744. eCollection 2022.
9
The role of aspirin, statins, colchicine, and IL-1 inhibitors in prevention of cardiovascular events: a systematic integrative review.阿司匹林、他汀类药物、秋水仙碱和白介素-1 抑制剂在预防心血管事件中的作用：系统综合评价。
J Osteopath Med. 2023 Oct 25;124(3):97-106. doi: 10.1515/jom-2023-0082. eCollection 2024 Mar 1.
10
Efficacy and safety of colchicine for pericarditis prevention. Systematic review and meta-analysis.秋水仙碱预防心包炎的疗效和安全性。系统评价和荟萃分析。
Heart. 2012 Jul;98(14):1078-82. doi: 10.1136/heartjnl-2011-301306. Epub 2012 Mar 22.

引用本文的文献

1
Efficacy and safety of colchicine in patients with acute coronary syndrome: a systematic review and meta-analysis of randomized controlled trials.秋水仙碱治疗急性冠状动脉综合征患者的疗效与安全性：一项随机对照试验的系统评价和荟萃分析
BMC Cardiovasc Disord. 2025 Sep 29;25(1):700. doi: 10.1186/s12872-025-05186-6.
2
Colchicine for Cardiovascular Prevention: Clarity Amidst the Confusion.用于心血管预防的秋水仙碱：混乱中的明晰
Am J Cardiovasc Drugs. 2025 Sep 1. doi: 10.1007/s40256-025-00754-9.